Crossfire Oncology
Company

Crossfire Oncology

Biotechnology Research Nl 15 employees
Employees
15
Contacts
2
Emails
2

Crossfire Oncology Overview

Headquarters
Nl
Industry
Biotechnology Research
Employees
15
Founded
2021
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Crossfire Oncology

Aberrant functioning of kinases is known to be an important driver in cancer. Targeting hereof has proven to be extremely successful and has already revolutionized the management of numerous types of cancer. At Crossfire Oncology we approach kinases from three different angles: inhibitors, degraders, and degrader antibody conjugates. This tailored approach allows us to design kinase targeting drugs that aim to maximize the therapeutic benefit for cancer patients.

Crossfire Oncology Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

Crossfire Oncology Org Chart

Sample employees and titles
Name Title Contact
Jan Gerard Sterrenburg Senior Scientist Chemistry at Crossfire
Email
Joeri De Wit Senior Scientist Chemistry at Crossfire
Email
Freek Van Cauter Crossfire Oncology - Senior Scientist
View
Winfried Mulder Molecular Biologist / Senior Scientist
View

Employees by Management Level

Senior / Lead 4 profiles

Crossfire Oncology Tech Stack

Data / AI 4 profiles

Compare Similar Companies to Crossfire Oncology